Latest DNA Chip Stories

Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck

2013-04-08 08:30:24

REDWOOD CITY, Calif. and SANTA CLARA, Calif., April 8, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, and Affymetrix®, Inc. (NASDAQ: AFFX) today announced that they will co-promote Ingenuity® iReport(TM) with Affymetrix expression microarray products effectively eliminating a bottleneck for researchers working with human, mouse and rat applications by coupling a fast and accurate statistical analysis and biological...

Genetic Test Reveals More About Potential Birth Defects Than Conventional Methods

2012-12-06 11:43:12

Lawrence LeBlond for redOrbit.com - Your Universe Online Two new papers published in the New England Journal of Medicine (NEJM) show that genetic testing in early pregnancy reveals far more about potential birth defects and stillbirth risk than current prenatal testing does, based on a multi-center clinical trial using both methods. The clinical trials showed that 6 percent of certain fetuses declared normal by conventional prenatal tests were found to have genetic abnormalities using...

Kinexus Announces the Launch of a New Antibody Microarray Kit

2012-11-27 08:27:32

New protein microarray kit is designed to aid researchers in lead discovery VANCOUVER, Nov. 27, 2012 /PRNewswire/ - Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced today the release of its first Kinex(TM) antibody microarray kit with its latest generation KAM-850 chip. The new antibody microarray is capable of tracking the levels and functional states of hundreds of diverse proteins in human and animal cell and tissue specimens and...

Markets for PCR, DNA Microarray, DNA Sequencing, Mass Spectrometry and Flow Cytometry to Exceed $50 billion by 2015

2012-11-05 20:23:28

FARMINGTON, Conn., Nov. 5, 2012 /PRNewswire-iReach/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. By 2015, the combined global markets for these five areas are expected to exceed $50 billion. (Photo: http://photos.prnewswire.com/prnh/20121105/CG06410) From now until December 31, Global Information Inc (GII), in exclusive partnership with our premium research...

CombiMatrix Corporation Selects Cartagenia BENCHlab CNV Platform to Bolster Expanded Lab Operations

2012-11-01 11:27:22

BOSTON, Nov. 1, 2012 /PRNewswire/ -- Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today that it has signed a license agreement for the Cartagenia BENCHlab CNV platform with CombiMatrix Corporation (Nasdaq: CBMX), a molecular diagnostics company. Irvine, CA-based CombiMatrix is a CLIA-certified and CAP-accredited, publicly-owned...

Genalyte Teams With Scienion To Provide Sciflexarrayer Dispensers For Its Maverick(TM) Detection Platform And Launches Custom Chip Spotting Service

2012-09-19 02:29:26

SAN DIEGO and BERLIN, Sept. 19, 2012 /PRNewswire/ -- Genalyte, Inc., a life sciences company developing and commercializing innovative next generation multiplexing technology, and Scienion AG, a life science company developing microarray and ultra-low volume liquid handling systems, today announced an agreement under which Genalyte will market Scienion's sciFLEXARRAYER(TM)( )automated liquid dispensers along with Genalyte's multiplexed Maverick(TM )Detection System. The...

Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray

2012-05-08 06:31:25

BELMONT, Calif., May 8, 2012 /PRNewswire/ -- Phalanx Biotech Group, a global genomic products and service provider, announces today the completion of manufacturing and testing for a proprietary targeted chromosomal microarray (CMA) designed specifically for prenatal and postnatal detection of microdeletions and microduplications related to a spectrum of congenital disorders, especially developmental and intellectual delay disorders. CytoOneArray® is capable of detecting 264...

Ingenuity Systems iReport Now Available: Fast, Accurate, Interactive Report for Gene Expression Data

2012-01-24 05:00:00

REDWOOD CITY, Calif., Jan. 24, 2012 /PRNewswire/ -- Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, today announced the general availability of Ingenuity® iReport(TM), a stand-alone report that provides the fastest way to get biological meaning from expression data. iReport provides a fully integrated, one-step solution for the statistical analysis and biological interpretation of gene expression data, eliminating the...

Microarrays Inc Introduces MI PathArray Assays for Apoptosis, Growth Factors, and Inflammation

2011-10-19 07:00:00

Specific Research Interests are the Focus of New Discovery Tool Huntsville, AL (PRWEB) October 19, 2011 Microarrays Inc (MI) launches its new MI PathArray assays for studying targeted biological pathways. These pathway-centric arrays provide the highest microarray sensitivity in the form of more sharply focused research-specialty arrays, in a multi-assay format. The MI PathArray assays bring a fresh research tool to laboratories involved in the exploration of biological pathways. MI...

Genetics & IVF Institute Offers Advanced Chromosome Analysis of Embryos

2011-10-10 09:00:00

Testing of 24 Chromosomes Screens Out Abnormal Embryos FAIRFAX, Va., Oct. 10, 2011/PRNewswire-USNewswire/ -- The Genetics & IVF Institute is now offering 24 Chromosome Microarray, which is a new, comprehensive test used as part of an IVF cycle to evaluate the number of chromosomes present in an embryo before it is transferred to the mother. Previous tests could examine only 5-12 chromosomes, so the 24 chromosome test is a major advance. (Logo:...